April 2017

Partnering with organizations to end malaria for good

The urgency, magnitude and global reach of malaria requires the commitment of all major stakeholders to work together providing expertise, investment and innovation.

The development of new solutions requires significant investment in time and resources. While Bayer has increased its R&D investment in Vector Control by 450 percent since 2006, through collaboration with external experts we are able to do more in a shorter period of time.

To this end, Bayer is proud to partner with the Innovative Vector Control Consortium (IVCC) since 2008 with the goal of developing together completely new solutions for vector control.

Today, 8 Bayer scientists are working on the pre-development phase of new active ingredients with the aim of bringing new solutions in the fight against malaria by 2022. Indeed, on the occasion of World Malaria Day, IVCC has expressed their appreciation for having Bayer as one of their product development partners, recognizing our work to end malaria for good.

To read the letter of thanks please click here.

IVCC is a Product Development Partnership investing donor funds in R&D to overcome barriers to innovation in vector control. Created in 2005 at the Liverpool School of Tropical Medicine by a grant from the Bill & Melinda Gates Foundation it has the mission to support the malaria elimination and eradication agenda, bringing new tools and products to public health markets that can combat the rapidly growing problem of insecticide resistance.

Click on the link below to get more information about the organizations with which Bayer is partnering in the fight against malaria.

Read more